Physician profile
Steven Michael Croft
NPI 1760682363
$5,454.55
in general payments reported to CMS, 2019-2025
20 companies · $96.01 in 2025
The $96.01 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $815 · 2021: $323 · 2022: $2,939 · 2023: $328 · 2024: $334 · 2025: $96.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $2,680.46 | 2019-2022 | |
| Ucb, INC. | $940.90 | 2019-2024 | Nayzilam, Briviact, Fintepla |
| Aquestive Therapeutics, INC. | $563.32 | 2019-2020 | |
| Sk Life Science, INC. | $427.53 | 2020-2025 | Xcopri |
| Jazz Pharmaceuticals INC. | $230.01 | 2022-2025 | Epidiolex |
| Immedica Pharma US, INC. | $92.50 | 2023-2024 | |
| Neurelis, INC. | $90.92 | 2020-2023 | Valtoco |
| Acadia Pharmaceuticals INC | $76.27 | 2019-2023 | Daybue |
| Aucta Pharmaceuticals, INC. | $69.93 | 2024-2025 | Motpoly Xr |
| Sumitomo Pharma America, INC. | $68.33 | 2024 | Aptiom |
| Biogen, INC. | $50.38 | 2021 | |
| Genzyme Corporation | $22.14 | 2019 | |
| Tanabe Pharma America, INC. | $22.02 | 2019 | |
| Kyowa Kirin, INC. | $20.03 | 2019 | |
| Abbott Laboratories | $18.40 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $17.70 | 2019 | |
| Medtronic USA, INC. | $17.18 | 2019 | |
| Allergan, INC. | $15.87 | 2020 | |
| Greenwich Biosciences, INC. | $15.58 | 2019 | |
| Ge Healthcare | $15.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Croft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.